Biotechnology

Home/Biotechnology

Gerry Elman is the Founding Editor of Biotechnology Law Report and a contributing author to the treatise Biotechnology Entrepreneurship. On this page are some pointers to some of our articles about biotechnology and the law.

Gerry’s chapter on Intellectual Property Protection for Biotechnology Inventions

By |2019-11-24T14:32:12-05:00June 18th, 2019|Biotechnology, Copyright, Intellectual Property, Patent, Trade Secret, Trademark|

Biotechnology Entrepreneurship Editor Craig Shimasaki and contributing author Gerry Elman Gerry Elman visited with Craig Shimasaki at the BIO International Convention in Philadelphia, June 5, 2019.  Craig is the editor of the treatise Biotechnology Entrepreneurship. Gerry and a co-author contributed the chapter on Intellectual Property Protection. Since the first edition was published in [...]

GE says bye-bye to biotech. … So it goes.

By |2020-01-01T08:45:00-05:00February 25th, 2019|Biotechnology, Patent|

February 25, 2019  — The Wall Street Journal headline reads: GE to Sell Its Biotech Business for $21 Billion.  I now know for certain that we're in a topsy-turvy world. Back in 1980 it was lawyers for the General Electric company that persuaded the U.S. Supreme Court to affirm, in the legendary decision of Diamond v. [...]

Supreme Court, snowed by ACLU smear campaign, resurrects archaic requirement of “invention” as a test of patent eligibility.

By |2020-02-17T12:03:49-05:00June 14th, 2013|Biotechnology, Intellectual Property, Patent|

In their decision June 13, 2013, in Association for Molecular Pathology v. Myriad Genetics, the Supreme Court seems to have been snowed by an anti-patent publicity campaign engineered by a brilliant but diabolical law professor and gullible lawyers at the venerable ACLU. The opinion of the Court resurrects an archaic requirement of "invention" that was [...]

US PTO to Hold Hearings on Effects of Patents on Genetic Testing

By |2012-02-16T08:06:31-05:00February 16th, 2012|Biotechnology, Intellectual Property, Patent, Patent Legislation|

Two hearings have been scheduled by the US PTO on the effect of patents for Genetic Testing, to support the study that the PTO is mandated by the Leahy-Smith America Invents Act ("AIA") to generate for Congress. The first of the hearings is today.  It will be broadcast via the Web. The second of the [...]

Go to Top